Navigation Links


Digestive at Biology News

Digestive at Biology Products

Mouse Paraffin Digestive Tissue Microarray from Zyagen Laboratories

Description:Zyagen tissue microarrays are derived from Paraffin embedded tissue blocks, which are subjected to rigorous quality control procedures to ensure the highest quality. Tissues of each array are manually assembled in one block, sectioned at a thickness of 5 microns and mounted on coated slides. Sections are large (3-5mm in diameter) in comparison to core sections made using Tissue Arrayer. Arrays en...
Company:Zyagen Laboratories

Mouse Frozen Digestive Tissue Microarray from Zyagen Laboratories

Description:Zyagen tissue microarrays are derived from frozen embedded tissue blocks, which are subjected to rigorous quality control procedures to ensure the highest quality. Tissues of each array are manually assembled in one block, sectioned at a thickness of 7microns and mounted on coated slides. Sections are large (3-5mm in diameter) in comparison to core sections made using Tissue Arrayer. Arrays enabl...
Company:Zyagen Laboratories

Rat Paraffin Digestive Tissue Microarray from Zyagen Laboratories

Description:Zyagen tissue microarrays are derived from Paraffin embedded tissue blocks, which are subjected to rigorous quality control procedures to ensure the highest quality. Tissues of each array are manually assembled in one block, sectioned at a thickness of 5 microns and mounted on coated slides. Sections are large (3-5 mm in diameter) in comparison to core sections made using Tissue Arrayer. Arrays e...
Company:Zyagen Laboratories
Digestive at Biology Technology
Digestive at Medicine News

Snake venom a treatment for digestive disease

Medical researchers from Irvene college,California report that proteins chemically related to snake venom and frog skin secretions may lead to the development of new treatments for a range of stubborn digestive disorders. The findings, mark the discovery of two naturally occurring human proteins, which the researchers have named prokineticins.How the proteins were //discovered is a ta...

Fructose cause digestive problems

An inability to digest fructose might explain common digestive symptoms like gas, pain and bloating.Researchers at the University of Iowa have been investigating the link between fructose intolerance and the symptoms of irritable bowel syndrome (IBS), a common disorder characterised by abdominal discomfort, bloating and changes in bowel habit. Fructose is the sugar found in various fruits and in...

Fructose cause digestive problems

An inability to digest fructose might explain common digestive symptoms like gas, pain and bloating.Researchers at the University of Iowa have been investigating the link between fructose intolerance and the symptoms of irritable bowel syndrome (IBS),// a common disorder characterised by abdominal discomfort, bloating and changes in bowel habit. Fructose is the sugar found in various fruits and i...

Infants at lower risk from digestive disease if introduced to cereal early

Infants may have lower risk for the disease of the intestine called celiac disease// if they are introduced to cereals at the age of 4 to 6 months. Researchers from University of Colorado at Denver and Health Sciences Center had reported that celiac disease, also called gluten-sensitive enteropathy, might have less chances of happening to children who are genetically more susceptible t...

Expandable metal stents used in digestive cancers

Dr. Todd H. Baron from Mayo Foundation in Rochester, Minnesota has created a break through of sorts by using expandable metal stents in the digestive tract of people afflicted with gastrointestinal cancers. These patients commonly suffer from obstructions and they present with symptoms like difficulty in swallowing, if the block is in the esophagus; they might present wi...

More>>

Digestive at Medicine Products
Digestive at Medicine Technology

ChemoCentryx Presents Positive Phase 2 Clinical Data for Traficet-EN in Crohn's Disease at the Digestive Disease Week 2007 Conference

Clear Anti-Inflammatory Activity Demonstrated Among Patients withActive Disease MOUNTAIN VIEW, Calif., May 23, 2007 /PRNewswire/ --ChemoCentryx, Inc., a clinical-stage biopharmaceutical companyfocused on discovering, developing and commercializingorally-administered therapeutics that target the chemokine system,presented data today from the company's Phase 2 clinical trial ofTraficet-EN...

Aquavan (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007

MINNEAPOLIS, May 23, 2007 (BUSINESS WIRE) -- MGI PHARMA, INC.(NASDAQ:MOGN), a biopharmaceutical company focused in oncology andacute care, today announced the presentation of results of asuccessful pivotal phase 3 trial of Aquavan(R) (fospropofoldisodium) Injection in patients undergoing colonoscopy. Primary andsecondary efficacy endpoint results, as well as safety data, werepresented at...

Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from 2006 Presented at Digestive Disease Week in Washington, D.C.

SOUTH SAN FRANCISCO, Calif., May 23, 2007 /PRNewswire-FirstCall/-- Napo Pharmaceuticals, Inc., , which focuses on the developmentand commercialization of proprietary pharmaceuticals for the globalmarketplace in collaboration with local partners, announced thatTrine Pharmaceuticals, Inc. ("Trine") is presenting a posterdetailing the results of a Phase 2a study conducted in 2006 forcrofele...

PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week

Nuvion Antibody Led to a Sustained Response and Remission inFollow-up to Phase 1 and Phase 1/2 studies and Was AdequatelyTolerated in Patients with IV Steroid-Refractory Ulcerative Colitis FREMONT, Calif., May 22, 2007 /PRNewswire-FirstCall/ -- Datapresented at the Digestive Disease Week (DDW) meeting this week inWashington D.C. by Dr. William Sandborn from the Mayo Clinicsuggest that Nuv...

New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At Annual Digestive Disease Week Meeting

AstraZeneca Focuses Research on Growing Childhood Condition WASHINGTON, May 22, 2007 /PRNewswire-FirstCall/ -- AstraZenecawill present several studies today regarding pediatric patientswith gastroesophageal reflux disease (GERD) during oral and postersessions at the annual Digestive Disease Week meeting held at theWashington Convention Center. The studies being presented further sup...

More>>

Digestive at Medicine Dictionary

Digestive Disorders

<br...

Digestive problems

The , <a href="/ ?q=/ Medicine-Dictionary/ gallbladd...
Other TagsSanSanSanSanSanSanlaunchedEntryEntryLakescircuitrydependspiecepiecepiece
(Date:7/25/2008)... The Retina Group of New York will present a...r degeneration especially designed for seniors. Th...ibrary at 116 Merritts Road, Farmingdale, NY 11735...ce is free and refreshments will be provided. The ...0. , Hicksville and Haupp...
(Date:7/25/2008)... The Drug Information Association (DIA) and ...he Critical Path Initiative (CPI) on the Move: Com...da, MD) and the Critical Path Transporter Workshop... Horsham, PA (PRWEB) July 25, 2005-- T...ociation (DIA)] and the Food and Drug Administrati...
(Date:7/25/2008)... Columbus-based law firm represents Pickerin...urchased at Columbus-area Kroger store , ...25, 2008 -- http://www.donaheyohioinjurylawyers.c...sonal injury law firms in central Ohio, has filed ...rt (Case No. 08CV9804) against The Kroger Co., in ...
(Date:7/24/2008)... Hoag to lease hospital facility on Sand Can...h, CA (Vocus) July 24, 2008 -- Hoag Memorial Hospi..., Inc. (NYSE: HCP), a Real Estate Investment Trust...-bed hospital facility on Sand Canyon Avenue near ...lity is currently operated by Tenet Healthcare Cor...
Breaking Medicine News(10 mins):Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2
(Date:7/25/2008)...niversity of Houston department of health and huma...of Second Life (SL) thanks to grants from the UH F...he Network Culture Project of the University of So...on. , "These funds will allow our faculty to sta...udents and our community," said Charles Layne, pro...
(Date:7/25/2008)...ALO, N.Y. -- Children born with hydrocephalus, or ... drain the fluid away from the brain to reduce har..., the rate of shunt infection in children is very ...ing the child through another surgery to replace t...ential additional neurological complications and a...
(Date:7/24/2008)...cal food shortages and growing demand for bio-fuel...ices rank among the greatest threats today to the ...mers and developers look for new areas for agricul...However, resisting pressures to convert wetlands i...e a suite of services essential to humanity, inclu...
(Date:7/24/2008)...es embedded with a telescope promise to make it ea...do other activities requiring sharper distance vis...scribe the advantages of these innovative glasses ...e May/June issue of Journal of Biomedical Optics ... , "This new design has several advantages," sa...
Breaking Biology News(10 mins):Second Life a first for UH department of health and human performance 2Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Rising energy, food prices major threats to wetlands as farmers eye new areas for crops 2Rising energy, food prices major threats to wetlands as farmers eye new areas for crops 3Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Olympus Announces 2008 Winners of Olympus Innovation Awards 14936 1Olympus Announces 2008 Winners of Olympus Innovation Awards 14936 2Olympus Announces 2008 Winners of Olympus Innovation Awards 14936 3Olympus Announces 2008 Winners of Olympus Innovation Awards 14936 4HealthMEDX Partners With Silverchair Learning Systems 14932 1HealthMEDX Partners With Silverchair Learning Systems 14932 2BARACLUDE 28R 29 28entecavir 29 Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside naive Chronic 1582 1BARACLUDE 28R 29 28entecavir 29 Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside naive Chronic 1582 2BARACLUDE 28R 29 28entecavir 29 Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside naive Chronic 1582 3BARACLUDE 28R 29 28entecavir 29 Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside naive Chronic 1582 4BARACLUDE 28R 29 28entecavir 29 Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside naive Chronic 1582 5BARACLUDE 28R 29 28entecavir 29 Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside naive Chronic 1582 6Obese Women Less Likely to Be Tested for Some Cancers 14930 1Obese Women Less Likely to Be Tested for Some Cancers 14930 2
Other Contentspericardiumpericardiumperitoneumperitoneumpersistencepersistencepersistence